Clostridium difficile infection: a review of the literature

被引:31
作者
Khan, Fahmi Yousef [1 ]
Elzouki, Abdul-Naser [1 ]
机构
[1] Hamad Med Corp, Hamad Gen Hosp, Dept Med, Doha, Qatar
关键词
Clostridium difficile infection; Nosocomial diarrhoea; Metronidazole; Vancomycin; Pseudomembranous colitis; HOSPITALIZED-PATIENTS; CONTROLLED TRIAL; DIARRHEA; DISEASE; VANCOMYCIN; DIAGNOSIS; COLITIS; STRAIN; TOXIN; PCR;
D O I
10.1016/S1995-7645(14)60197-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Clostridium difficile is a Gram-positive, strictly anaerobic, spore-forming bacterium. It is the most common cause of antibiotic-associated diarrhea in hospitals and other healthcare facilities and is of significant concern because of the increasing morbidity and mortality rates as well as increased health care costs. Spectrum of presentation of Clostridium difficile infection ranges from mild, self-limiting diarrhea, to serious diarrhea, pseudomembranous colitis and life threatening fulminant colitis, which may result in death. Prompt identification of patients with symptomatic Clostridium difficile infection is essential as the majority of patients respond quickly to antimicrobial therapy. Prevention is best accomplished by implementation of infection control measures and by judicious use of antimicrobial agents.
引用
收藏
页码:S6 / S13
页数:8
相关论文
共 73 条
[1]   Recurrent Clostridium difficile colitis:: Case series involving 18 patients treated with donor stool administered via a nasogastric tube [J].
Aas, J ;
Gessert, CE ;
Bakken, JS .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) :580-585
[2]   Fulminant Clostridium difficile colitis [J].
Adams, Sasha D. ;
Mercer, David W. .
CURRENT OPINION IN CRITICAL CARE, 2007, 13 (04) :450-455
[3]   Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates [J].
Åkerlund, T ;
Svenungsson, B ;
Lagergren, Å ;
Burman, LG .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (02) :353-358
[4]   Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease [J].
Al-Nassir, Wafa N. ;
Sethi, Ajay K. ;
Li, Yuejin ;
Pultz, Michael J. ;
Riggs, Michelle M. ;
Donskey, Curtis J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (07) :2403-2406
[5]  
ANAND A, 1994, AM J GASTROENTEROL, V89, P519
[6]   Evaluation of the Cepheid Xpert Clostridium difficile Epi Assay for Diagnosis of Clostridium difficile Infection and Typing of the NAP1 Strain at a Cancer Hospital [J].
Babady, N. Esther ;
Stiles, Jeffrey ;
Ruggiero, Phyllis ;
Khosa, Perminder ;
Huang, David ;
Shuptar, Susan ;
Kamboj, Mini ;
Kiehn, Timothy E. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (12) :4519-4524
[7]   Treating Clostridium difficile Infection With Fecal Microbiota Transplantation [J].
Bakken, Johan S. ;
Borody, Thomas ;
Brandt, Lawrence J. ;
Brill, Joel V. ;
Demarco, Daniel C. ;
Franzos, Marc Alaric ;
Kelly, Colleen ;
Khoruts, Alexander ;
Louie, Thomas ;
Martinelli, Lawrence P. ;
Moore, Thomas A. ;
Russell, George ;
Surawicz, Christina .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (12) :1044-1049
[8]   Antibiotic-associated diarrhea [J].
Bartlett, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (05) :334-339
[9]   Clostridium difficile infection in Europe: a hospital-based survey [J].
Bauer, Martijn P. ;
Notermans, Daan W. ;
van Benthem, Birgit H. B. ;
Brazier, Jon S. ;
Wilcox, Mark H. ;
Rupnik, Maja ;
Monnet, Dominique L. ;
van Dissel, Jaap T. ;
Kuijper, Ed J. .
LANCET, 2011, 377 (9759) :63-73
[10]   Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm? [J].
Bobak, D. ;
Arfons, L. M. ;
Creger, R. J. ;
Lazarus, H. M. .
BONE MARROW TRANSPLANTATION, 2008, 42 (11) :705-713